Trial Outcomes & Findings for Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade (NCT NCT00938782)

NCT ID: NCT00938782

Last Updated: 2015-02-19

Results Overview

The exact time from end of last anesthetic drug to time of tracheal extubation.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

67 participants

Primary outcome timeframe

Measured from time of end anesthesia to time of tracheal extubation.

Results posted on

2015-02-19

Participant Flow

Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups.

Participant milestones

Participant milestones
Measure
1 - SEDLine™ Group
Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on vital plus Sedline monitor.
2- Control Group
Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on physiologic vitals without input from Sedline monitor.
Overall Study
STARTED
32
35
Overall Study
COMPLETED
32
35
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1 - SEDLine™ Group
n=32 Participants
Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on vital plus Sedline monitor. Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups: a group whose titration of sevoflurane was based on SEDLine™ data (SEDLine™ group).
2 - CONTROL Group
n=35 Participants
Surgical patient group randomized to active monitoring with Sedline monitor plus other routine monitors. Anesthesia protocol developed with respect to titrate based on physiologic vitals without input from Sedline monitor. Surgical patients older than 65 years of age receiving beta-adrenergic blockers for a minimum of 24 hours preoperatively were randomized to two groups: a group whose titration of sevoflurane was not based on SEDLine™ data (CONTROL group)
Total
n=67 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
32 Participants
n=5 Participants
35 Participants
n=7 Participants
67 Participants
n=5 Participants
Age, Continuous
75 years
STANDARD_DEVIATION 5.7 • n=5 Participants
74.5 years
STANDARD_DEVIATION 6.7 • n=7 Participants
74.8 years
STANDARD_DEVIATION 6.2 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
11 Participants
n=7 Participants
23 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
24 Participants
n=7 Participants
44 Participants
n=5 Participants
Region of Enrollment
United States
32 participants
n=5 Participants
35 participants
n=7 Participants
67 participants
n=5 Participants

PRIMARY outcome

Timeframe: Measured from time of end anesthesia to time of tracheal extubation.

Population: All patients enrolled in both groups.

The exact time from end of last anesthetic drug to time of tracheal extubation.

Outcome measures

Outcome measures
Measure
1 - Sedline Group
n=32 Participants
Patient group randomized to active monitoring with Sedline monitor.
2 - Control Group
n=35 Participants
Patient groups randomized to active monitoring versus blinded monitoring. This group had teh clinician blinded to output of the Sedline monitor.
Time to Extubation
13.0 minutes
Standard Deviation 5.9
12.5 minutes
Standard Deviation 7.4

Adverse Events

1 - SEDLine Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group 2 - Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. David R Drover

Stanford University

Phone: 650-725-0364

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place